Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: Randomized placebo-controlled, double blind clinical trial

Phytotherapy Research

Volumn 15, Issue 4, 2001, Pages 344-350

  Schmid, B ^a   Ludtke R ^b   Selbmann, H K ^b   Kotter I ^b   Tschirdewahn, B ^c   Schaffner, W ^d   Heide, L ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c Federseeklinik   (Germany)

^d UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Herbal remedies; Osteoarthritis; Salix; Willow bark; WOMAC

Indexed keywords

PLACEBO; SALICIN; SALIX EXTRACT;

ADULT; ARTICLE; BLOOD TOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL SYMPTOM; HEADACHE; HUMAN; HYPERTRIGLYCERIDEMIA; INFECTION; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MUSCULOSKELETAL DISEASE; OSTEOARTHRITIS; OUTCOMES RESEARCH; PAIN; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; RIGIDITY; SKIN MANIFESTATION; SOMNOLENCE;

ADULT; ANALGESICS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOARTHRITIS, HIP; OSTEOARTHRITIS, KNEE; PAIN; PAIN MEASUREMENT; PLANT EXTRACTS; PLANTS, MEDICINAL; QUESTIONNAIRES; ROSALES; TREATMENT OUTCOME; TREES;

SALIX;

EID: 0034952428     PISSN: 0951418X     EISSN: None     Source Type: Journal    
DOI: 10.1002/ptr.981     Document Type: Article

References (24)

1. Criteria for classification of clinical osteoarthritis
2. A hesitant look at the future
3. Signal measurement strategies: Are they feasible and do they offer any advantage in outcome measurement in osteoarthritis
4. Validation study of WOMAC: A health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee
5. A multicenter study of tenoxicam and diclofenac in patients with osteoarthritis of the knee
6. Double-blind randomized controlled trial of sodium mecofenamate (Meclomen) and diclofenac sodium (Voltaren): Post validation reapplication of the WOMAC osteoarthritis index
7. Recommendations for a core set of outcome measures for future phase III clinical trials in knee, hip and hand osteoarthritis. Consensus development at OMERACT III
8. Treatment of low back pain exacerbations with willow bark extract: A randomized double-blind study
9. Salicis cortex - Willow Bark
10. Design and conduct of clinical trials in osteoarthritis: Preliminary recommendations from a task force of the Osteoarthritis Research Society
11. A chemotaxonomic survey of phenolics in leaves of northern Salicaceae species
12. Indices of severity and disease activity for osteoarthritis
13. Clinical features of osteoarthritis
14. Biologische salicylattherapie mit cortex salicis
15. Identifikation und bestimmung von je acht phenolglykosiden in salix purpurea und salix daphnoides mit moderner HPLC
16. Weidenrinden-qualität: Gesamtsalicinbestimmung in weidenrinden und weidenrindenpräparaten mit HPLC
17. Effect of a proprietary herbal medicine on the relief of chronic arthritic pain: A double-blind study
18. Bioverfügbarkeit von salicylsäure und coffein aus einem phytoanalgetischen kombinationspräparat
19. Weidenrinde - Ein antirheumatikum der modernen phytotherapie?
20. An account of the success of the bark of the willow in the cure of agues
21. Analytische und biologische untersuchungen an salicaceen-wirkstoffen, insbesondere an salicin: I. Identifizierungs-, isolierungs- und bestimmungsmethoden
22. Evaluation einer deutschen version des WOMAC
23. Phytotherapie in der behandlung extraartikulärer rheumaerkrankungen